ReviewPediatric clinics of North America2017
Pathophysiology and Management of Acute Respiratory Distress Syndrome in Children.
Review in Pediatric clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 45 citations in OpenAlex.
- A novel oxygenation distension index (ODI): a driving pressure-based metric compared with the oxygenation index in pediatric PARDS.European journal of pediatrics · 2026Observational
- Medication-induced lung disease in children.Pediatric radiology · 2026Review
- CPAP caps are associated with restricted head growth and altered skull morphology in newborn infants.Frontiers in pediatrics · 2025Article
- Increased Levels of hsa-miR-199a-3p and hsa-miR-382-5p in Maternal and Neonatal Blood Plasma in the Case of Placenta Accreta Spectrum.International journal of molecular sciences · 2024Article
- Predictors of Failure of Noninvasive Ventilation in Critically Ill Children.Journal of pediatric intensive care · 2023Article
- State-of-the-art management of the acutely unwell child.Anaesthesia · 2022Review
- Exome sequencing contributes to identify comorbidities in a rare case of infant ARDS induced by the CD40LG mutation.BMC medical genomics · 2022Article
- Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies.Pharmaceutics · 2022Review
- Acute Respiratory Distress Syndrome Management in Pediatric Intensive Care Units in Turkey: A Prospective Survey.Turkish archives of pediatrics · 2022Article
- Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.Acta pharmaceutica Sinica. B · 2022Review
- Article
- Efficacy of intratracheal budesonide-surfactant combined therapy in surfactant-insufficient rat lungs with lipopolysaccharide insult.Journal of the Chinese Medical Association : JCMA · 2021Article
- The Clinical Characteristics of ARDS in Children With Hematological Neoplasms.Frontiers in pediatrics · 2021Article
- Sugammadex: Applications in Pediatric Critical Care.Journal of pediatric intensive care · 2020Review
- Sedation strategies in children with pediatric acute respiratory distress syndrome (PARDS).Annals of translational medicine · 2019Review
- The Current State of Pediatric Acute Respiratory Distress Syndrome.Pediatric allergy, immunology, and pulmonology · 2019Review
- Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
Acute respiratory distress syndrome (ARDS) is a syndrome of noncardiogenic pulmonary edema and hypoxia that accompanies up to 30% of deaths in pediatric intensive care units. Pediatric ARDS (PARDS) is diagnosed by the presence of hypoxia, defined by oxygenation index or Pao
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.